β-galactosidase-activated red fluorescent probe assists in the diagnosis of pancreatitis

Jiemin Wang,Zhongsheng Xu,Xinhua Zheng,Wenwu Qin,Xinyao Gao,Yalong Zheng,Fei Lian,Qian Jiang,Yun Liu,Shuai Fan
DOI: https://doi.org/10.1016/j.saa.2024.125265
IF: 4.831
2024-10-16
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
Abstract:Acute pancreatitis (AP) is an acute inflammatory disease resulting from abnormal digestion of itself and surrounding organs by pancreatic enzymes caused by a variety of pathogenic factors. When the tissue of a biological organism is afflicted with pancreatitis and experiences swelling, bleeding, and necrotic injuries, the abnormal expression of β-galactosidase (β-Gal) activity becomes one of the main indicators for assisting in the diagnosis of pancreatitis. In this study, a highly specific red fluorescent probe designed for the detection of β-Gal activity has been developed. β-galactoside is used as the enzyme activating group, and the long-wavelength luminescent water-soluble organic molecule NBDOH is used as the luminophore to construct the fluorescent probe NBD-gal . NBD-gal is activated by abnormally overexpressed β-Gal, releasing a strong red fluorescent signal. The new fluorescent probe developed in this study is used to assist in the diagnosis of pancreatitis by detecting abnormal expression of β-Gal activity in vivo. In in vivo imaging experiments, NBD-gal can effectively differentiate between normal nude mice and pancreatitis nude mice. In addition, NBD-gal can be effectively localized in real-time to the pancreas and intestines, which are rich in β-Gal in nude mice. Therefore, NBD-gal exerts great potential in the early diagnosis, treatment, and prevention of biomedical clinical pancreatitis.
spectroscopy
What problem does this paper attempt to address?